nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts
|
Gourdeau, Henriette |
|
2002 |
50 |
6 |
p. 490-496 |
artikel |
2 |
Clinical pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase inhibitor ABT-518
|
Crul, Mirjam |
|
2002 |
50 |
6 |
p. 473-478 |
artikel |
3 |
Cytosolic and microsomal activation of doxifluridine and tegafur to produce 5-fluorouracil in human liver
|
Ozawa, Shogo |
|
2002 |
50 |
6 |
p. 454-458 |
artikel |
4 |
Decreased tumor blood flow as measured by positron emission tomography in cancer patients treated with interleukin-1 and carboplatin on a phase I trial
|
Logan, Theodore F. |
|
2002 |
50 |
6 |
p. 433-444 |
artikel |
5 |
Development of an optimal pharmacokinetic sampling schedule for rubitecan administered orally in a daily times five schedule
|
Schoemaker, Nadja E. |
|
2002 |
50 |
6 |
p. 514-517 |
artikel |
6 |
Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat
|
Liu, Jing |
|
2002 |
50 |
6 |
p. 445-453 |
artikel |
7 |
In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSCĀ 680410 against human leukemia and glioblastoma cell lines
|
Avramis, Ioannis A. |
|
2002 |
50 |
6 |
p. 479-489 |
artikel |
8 |
Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia
|
Cortes, Jorge |
|
2002 |
50 |
6 |
p. 497-500 |
artikel |
9 |
Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol
|
Thomas, James P. |
|
2002 |
50 |
6 |
p. 465-472 |
artikel |
10 |
The doxorubicin-cardioprotective drug dexrazoxane undergoes metabolism in the rat to its metal ion-chelating form ADR-925
|
Schroeder, Patricia E. |
|
2002 |
50 |
6 |
p. 509-513 |
artikel |
11 |
The raltitrexed-vinorelbine combination: a phase I pharmacokinetic and pharmacodynamic trial in advanced breast cancer
|
Ferrero, Jean-Marc |
|
2002 |
50 |
6 |
p. 459-464 |
artikel |
12 |
Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice
|
Papadopoulou, Maria V. |
|
2002 |
50 |
6 |
p. 501-508 |
artikel |